Page-1
VICC MEL 0823 Adjuvant immunotherapy with anti-CTLA-4... ECOG MEL E1697 Phase III
*2nd Priority Randomized Study of 4... See Stage IV Trials VICC MEL 0474 Multicenter Selective Lymphadenectomy Trial II... ECOG MEL E1697 Phase III
*2nd Priority Randomized Study of 4... VICC MEL 0287 Melanoma and Pigmented Lesions Repository Click here to print
this page (PDF) Melanoma Flowcharts